Literature DB >> 11447373

Urine catecholamine concentrations and psychophysical stress in elite tennis under practice and tournament conditions.

A Ferrauti1, G Neumann, K Weber, J Keul.   

Abstract

BACKGROUND: The purpose of the study was to specify and define the differences of psychophysical stress in elite tennis players under practice and tournament conditions.
METHODS: Basal, pre- and postcompetition urine samples of 26 nationally ranked players (NR) were analysed for concentrations of epinephrine (EPI) and norepinephrine (NE) under practice (P) and tournament conditions (T). Results were completed by the values obtained from two internationally ranked players (IR) competing in 6 (player A) and 5 (player B) Davis-Cup matches, respectively.
RESULTS: In NR, pre- and postcompetition concentrations for EPI were significantly higher under tournament conditions (T: 1.33+/-0.65 and 3.66+/-2.51 microg/100 mg creatinine vs P: 0.61+/-0.39 and 0.97+/-0.59 microg/100 mg creatinine). The NE/EPI ratio showed significantly inverse results (T: 3.53+/-1.87 and 3.58+/-1.59 vs P: 8.08+/-6.99 and 10.03+/-6.58), whereas the concentration of NE did not differ between the two conditions. Significant correlations were found between the level of perceived nervousness (ten-point-likert scale) and the postcompetition concentration of EPI (r=0.491, p<0.05) and the NE/EPI ratio (r=-0.595, p<0.01). Players who felt affected by nervousness in their performance outcome showed significantly lower NE/EPI ratios (2.73+/-1.44 vs 4.49+/-2.54, p<0.05). The Davis-Cup-Players showed intra-individually constant but inter-individually different concentrations of EPI (A= 2.2+/-0.5 vs B= 7.0+/-0.8 microg/100 mg creatinine), NE (A= 7.4+/-2.2 vs B= 15.5+/-3.2 microg/100 mg creatinine) and the ratio of NE/EPI (A= 3.7+/-2.2 vs B= 2.2+/-0.7).
CONCLUSIONS: In tennis tournaments, sympathetic activity is increased due to a higher psychological stress which may impair performance. Practical efforts should focus on psycho-regulative methods and psychophysical regeneration for players dealing with a chronic sympathetic hyper-activation.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11447373

Source DB:  PubMed          Journal:  J Sports Med Phys Fitness        ISSN: 0022-4707            Impact factor:   1.637


  7 in total

Review 1.  Carbohydrate intake and tennis: are there benefits?

Authors:  M S Kovacs
Journal:  Br J Sports Med       Date:  2006-05       Impact factor: 13.800

2.  Match activity and physiological responses during a junior female singles tennis tournament.

Authors:  Jaime Fernandez-Fernandez; Alberto Mendez-Villanueva; Benjamin Fernandez-Garcia; Nicolas Terrados
Journal:  Br J Sports Med       Date:  2007-06-11       Impact factor: 13.800

3.  Unexpected benefits: pathways from smoking restrictions in the home to psychological well-being and distress among urban Black and Puerto Rican Americans.

Authors:  Kerstin Pahl; Judith S Brook; Jonathan Koppel; Jung Yeon Lee
Journal:  Nicotine Tob Res       Date:  2011-04-15       Impact factor: 4.244

4.  Comparison of visual acuity in reduced lumination and facility of ocular accommodation in table tennis champions and non- players.

Authors:  Ebrahim Jafarzadehpur; Mohammad R Yarigholi
Journal:  J Sports Sci Med       Date:  2004-03-01       Impact factor: 2.988

Review 5.  Interactive processes link the multiple symptoms of fatigue in sport competition.

Authors:  Axel J Knicker; Ian Renshaw; Anthony R H Oldham; Simeon P Cairns
Journal:  Sports Med       Date:  2011-04-01       Impact factor: 11.136

6.  Effects of the tennis tournament on players' physical performance, hormonal responses, muscle damage and recovery.

Authors:  Tuomo Ojala; Keijo Häkkinen
Journal:  J Sports Sci Med       Date:  2013-06-01       Impact factor: 2.988

7.  An Accurate and Rapid System to Identify Play Patterns in Tennis using Video Recording Material: Break Point Situations as a Case Study.

Authors:  Iván Prieto-Lage; M A Prieto; Thomas P Curran; Alfonso Gutiérrez-Santiago
Journal:  J Hum Kinet       Date:  2018-06-13       Impact factor: 2.193

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.